These international patent data are derived from patent families, based on US drug-patent linkages. Accordingly, they should not be regarded as comprehensive records of ex-US drug-patent associations.
For data on generic availability, patent expirations, legal action that postpones generic launch
— Clinical pharmacist, USA
information on patent expiries and potential generic entrants
— Consultant, USA
To identify branded drug patent expiration and generic market entry
— CRO project manager, Portugal
To see which patents for drugs are expiring to do pipeline planning for our company
— Business development manager, South Africa
For information about patents on drugs of interest
— Information consultant, Mexico
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
